IP Library › Granted Patent US 12,048,793
Granted Patent B2
US 12,048,793 · App. 17/251,552 · Granted Jul 30, 2024

Medication infusion devices, systems, and methods

Inventors: Bryan T. Oronsky (Los Altos Hills, CA); Scott Caroen (San Francisco, CA); Tony R. Reid (San Diego, CA); Jeannie Williams (Fairfax Station, VA)
Assignee: EPICENTRX, INC.
A61M1/342A61M1/3673A61M1/38A61M2202/0216A61M2202/0275A61M2205/3337A61M2205/7545
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,048,793
App. No.
17/251,552
Granted
Jul 30, 2024
Kind
B2
Abstract

Devices, systems, and methods for medication infusion are described herein. In some embodiments, a system includes a patient access subassembly, a first fluid reservoir, a second fluid reservoir, and an assembly. The assembly can have a first configuration in which the patient access subassembly is in fluid communication with the first fluid reservoir via a first tube, a second configuration in which the first fluid reservoir is in fluid communication with the second fluid reservoir, and a third configuration in which the first fluid reservoir is in fluid communication with the patient access subassembly via a second tube, the first fluid reservoir fluidically isolated from the first tube in the third configuration.

Claims (24)

1. A method, comprising:

coupling a patient access subassembly to a patient, wherein the patient access subassembly is fluidically coupled to a first fluid reservoir containing a first substance and a second fluid reservoir containing a second substance via an assembly;

drawing cells through the patient access subassembly, through the assembly, and into the first fluid reservoir such that the cells and the first substance form a third substance;

manipulating the assembly such that the first fluid reservoir is fluidically isolated from the patient access subassembly and the first fluid reservoir is in fluidic communication with the second fluid reservoir;

transferring a portion of the third substance from the first fluid reservoir through the assembly and into the second fluid reservoir such that the portion of the third substance and the second substance form a fourth substance;

transferring the fourth substance from the second fluid reservoir through the assembly and into the first fluid reservoir such that a remainder of the third substance and the fourth substance form a fifth substance;

manipulating the assembly such that the first fluid reservoir is in fluidic communication with the patient access subassembly;

transferring the fifth substance from the first fluid reservoir through the assembly, through the patient access subassembly, and into the patient;

fluidically coupling a third fluid reservoir containing a saline solution to the assembly;

manipulating the assembly such that the third fluid reservoir is in fluidic communication with the patient access subassembly via the assembly; and

transferring at least a portion of the saline solution from the assembly to the patient access subassembly.

2. The method of claim 1 , wherein:

the portion of the third substance has a first volume,

the fourth substance has a second volume, and

the second volume is at least two times the size of the first volume.

3. The method of claim 1 ,

wherein drawing the cells from the patient access subassembly draws the cells into the assembly from the patient access subassembly via a first flow path,

wherein transferring the fifth substance to the patient access subassembly and into the patient transfers the fifth substance out of the assembly and to the patient access subassembly via a second flow path, and

wherein the first flow path is different from the second flow path.

4. The method of claim 1 , wherein manipulating the assembly comprises adjusting an orientation of one or more valves of the assembly.

5. The method of claim 1 , wherein the first substance comprises an anticoagulant.

6. The method of claim 1 , wherein the second substance comprises a medicament.

7. The method of claim 6 , wherein the medicament comprises 2-Bromo-1-(3,3-dinitroazetidin-1-yl)ethanone, a dinitroazetidine, propofol, a nitric oxide donor, nitric oxide, ozone, an electrophile, a chemotherapy drug, or a combination thereof.

8. The method of claim 1 , wherein the cells comprise packed red blood cells, white blood cells, and platelets, or a combination thereof.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 11, 2022
From: ORONSKY, BRYAN T.; CAROEN, SCOTT; REID, TONY R.; WILLIAMS, JEANNIE
To: EPICENTRX, INC.
Reel/Frame 061740/0314 →
Continuity (2)
Provisional Application 62683389 · Jun 11, 2018
Related Publication 20210244870A1 · Aug 12, 2021
Cited By (2)
US 12,357,607 US 12,357,608